Do cephalosporins potentiate or antagonize aminoglycoside nephrotoxicity?
D000617:Aminoglycosides / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D002511:Cephalosporins / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins